QP
Quoin Pharmaceuticals Ltd.
SEC filingPharmaceuticals · Ashburn, VA
Amount raised$50Msold at filing
Total offering$50M
Investors in the raise33count reported to the SEC
FiledSep 10, 2026first sale Aug 31, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Michael Bridget SemberDirector
Denise Bridget CarterExecutive Officer, Director
James Bridget CulverwellDirector
Dennis Bridget LangerDirector
Sally Bridget LawlorExecutive Officer
Natalie Bridget LeongDirector
Joseph Bridget CooperDirector
Michael MyersExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.